Biomarkers in gestational diabetes: from traditional to immunological

Authors

Keywords:

gestational diabetes; early prediction; biomarkers; inflammation; flow cytometry

Abstract

Gestational diabetes (GD) is often diagnosed late, identifying the disease after it has already developed. This letter proposes an integrated model for early prediction in high-risk women, such as those with obesity. In addition to traditional markers like an altered lipid profile (elevated triglycerides) and elevated uric acid levels in the first trimester, it is crucial to incorporate immunological biomarkers.

Downloads

Download data is not yet available.

Author Biographies

Elizabeth Machin Parapar , Mariana Grajales Coello University Gynecological and Obstetrical Hospital, Santa Clara, Villa Clara, Cuba

First-Degree Specialist in Gynecology, Obstetrics and Gynecology

Heidy Isabel González Aguiar, Mariana Grajales Coello University Gynecological and Obstetrical Hospital, Santa Clara, Villa Clara, Cuba

First-Degree Specialist in Gynecology, Obstetrics and Gynecology

Juan Antonio Suarez Gonzalez, Mariana Grajales Coello University Gynecological and Obstetrical Hospital, Santa Clara, Villa Clara, Cuba

Specialist in Gynecology and Obstetrics (Levels I and II). Assistant Professor

References

1. Mittal R, Prasad K, Lemos JRN, Arevalo G, Hirani K. Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management. Int J Mol Sci [Internet]. 2025 [citado 05/12/2025]; 26(5): [aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40076938/

https://doi.org/10.3390/ijms26052320

2. Nonso Iheagwam F, Toyin Iheagwam O. Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategies. Medicine in Novel Technology and Devices [Internet]. 2025 [citado 05/12/2025]; 25(2): [aprox. 3p.] https://doi.org/10.1016/j.medntd.2025.100351 https://www.sciencedirect.com/science/article/pii/S2590093525000025

3. Aamodt KI, Powers AC. The pathophysiology, presentation and classification of Type 1 diabetes. Diabetes Obes Metab [Internet]. 2025 [citado 05/12/2025]; 27(Suppl 6): [aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/40734585/

https://doi.org/10.1111/dom.16628

4. Soeatmadji DW, Rosandi R, Saraswati MR, Sibarani RP, Tarigan WO. Clinicodemographic Profile and Outcomes of Type 2 Diabetes Mellitus in the Indonesian Cohort of DISCOVER: A 3-Year Prospective Cohort Study. J ASEAN Fed Endocr Soc [Internet]. 2023 [citado 05/12/2025]; 38(1): [aprox. 2p.].Disponible en: https://asean-endocrinejournal.org/index.php/JAFES/article/view/1917

https://doi.org/10.15605/jafes.038.01.10

5. Zhou Z, Sun B, Yu D, Zhu C. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus. Frontiers in Cellular and Infection Microbiology [Internet]. 2022 [citado 05/12/2025]; 12: [aprox. 3p.].Disponible en: https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2022.834485

https://doi.org/10.3389/fcimb.2022.834485

6. Qi J, Wu B, Chen X, Wei W, Xudong Y. Diagnostic biomolecules and combination therapy for pre-eclampsia. Reprod Biol Endocrinol [Internet]. 2022 [citado 05/12/2025]; 20(136): [aprox. 3p.]. Disponible en: https://link.springer.com/article/10.1186/s12958-022-01003-3

https://doi.org/10.1186/s12958-022-01003-3

7. Borroto Mederos Y, Tiza Pérez Y, Pérez Valencia B. Caracterización del paciente diabético como antecedente para una intervención educativa. Medicentro Electrónica [Internet]. 2023 [citado 05/12/2025]; 28/1): [aprox. 3p.]. Disponible en:https://medicentro.sld.cu/index.php/medicentro/article/view/4067/3267

8. Xotlanihua-Gervacio MC, Valenzuela OL, Rodríguez-Ruiz A, Viveros-Contreras R, Balderas-Vázquez C, Méndez-Bolaina E, et al. Los estados hematológico y nutricional se asocian con el desarrollo de preeclampsia en una población mexicana. Nutr Hosp [Internet]. 2023 [citado 05/12/2025]; 40(1): [aprox. 3p.]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112023000100011&lng=es

https://dx.doi.org/10.20960/nh.04110

9. Sueldo MA, Rivera MA, Sánchez-Zambrano MB, Zilberman J, Múnera-Echeverri AG, Paniagua M, et al. Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención primaria de enfermedad cardiovascular en la mujer. Arch Cardiol Méx [Internet]. 2022 [citado 05/12/2025]; 92(Suppl 2): [aprox. 2p.]. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405-99402022000600001&lng=es

https://doi.org/10.24875/acm.22000071

10. Carnib BL, Souza EV, Floresta LRS, Marques Lage T, Rodrigues IR, et al. Therapeutic applications of alpha-lipoic acid: A review of clinical and preclinical evidence (1998–2024). Biomed Pharmacother [Internet]. 2025 [citado 05/12/2025]; 191:[aprox. 2p.].Disponible en: https://www.sciencedirect.com/science/article/pii/S0753332225006742

https://doi.org/10.1016/j.biopha.2025.118480

Downloads

Published

2026-04-01

How to Cite

1.
Machin Parapar E, González Aguiar HI, Suarez Gonzalez JA. Biomarkers in gestational diabetes: from traditional to immunological. Acta Méd Centro [Internet]. 2026 Apr. 1 [cited 2026 Apr. 3];20:e2402. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/2402

Issue

Vol. 20 (2026): PUBLICACIÓN CONTINUA

Section

Letters to the Editor

License

Copyright (c) 2026 Elizabeth Machin Parapar , Heidy Isabel González Aguiar, Juan Antonio Suarez Gonzalez

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).